You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫美板塊拉昇走強 華熙生物大漲超8%
格隆匯 05-25 10:59
格隆匯5月25日丨醫美板塊拉昇走強,華熙生物大漲超8%,愛美客漲超7%,貝泰妮漲超6%,華東醫藥、奧園美谷、朗姿股份等紛紛跟漲。據艾媒諮詢數據顯示,2016-2020年,中國醫美市場規模超過3000億元,同比增長23%。隨着消費觀念不斷升級,人們將消費重心逐漸從物質消費向喜好消費偏移,因此愛美的人們也撐起了龐大的醫美市場。機構指出,隨着人均可支配收入增加、醫美的普及程度提高、法規監管逐漸完善等有利因素的推動,我國醫美市場現處於高速發展階段。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account